|Articles|May 12, 2022
Predictive Pooling Strategy: Global Biotech Company Reduces Risk in Downstream Purification
Author(s)Aizon
Read this case study on a large global biotechnology company that was looking to explore predictive models to improve the yield of their downstream bioprocess using historical data.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
3
FDA, Duke University Planning Epinephrine Access Workshop for December
4
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
5
